Nachrichten zur Johnson & Johnson Aktie

J&J to buy Abiomed in $16.6 billion deal

...(Reuters) - Johnson & Johnson said on Tuesday it will acquire......…

UPDATE 1-J&J to buy Abiomed in $16.6 bln deal

...(Adds deal details) Nov 1 (Reuters) - Johnson & Johnson said......…

Abiomed stock rockets after J&J buyout deal valued at $16.6 billion

Shares of Abiomed Inc. rocketed 48.8% toward a 14-month high in premarket trading Tuesday, after the provider of medical…

Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal

Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal...…

Johnson & Johnson to Acquire Abiomed

NEW BRUNSWICK, N.J. & DANVERS, Mass.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ), the worlds largest, most diversified healthcare products company, and…

J&J to buy Abiomed in $16.6 bln deal

...Nov 1 (Reuters) - Jonhson & Johnson said on Tuesday it will acquire......…

Johnson & Johnson stock outperforms market despite losses on the day

Johnson & Johnson stock outperforms market despite losses on the day...…

J&J suspends enrollment in clinical trial assessing Essa Pharmas prostate cancer treatment

Shares of Essa Pharma Inc. fell 28.6% in premarket trading on Monday after the company said Johnson & Johnson…

Sonnet stock soars 16% on collaboration with J&J for 3 drug compounds

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ESSA drops 26% as Johnson & Johnson ends trial enrollment for lead asset

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bundesrat Guy Parmelin eröffnet den modernsten Innovationspark der Schweiz

Rund 70 Prozent der Fläche sind an 38 Firmen und Institutionen vermietet, darunter zahlreiche Startups, aber auch grosse Unternehmen wie…

Johnson & Johnson stock rises Friday, still underperforms market

Johnson & Johnson stock rises Friday, still underperforms market...…

The Zacks Analyst Blog Highlights UnitedHealth Group, Johnson & Johnson, Walmart, The Coca-Cola Company and NVIDIA

UnitedHealth Group, Johnson & Johnson, Walmart, The Coca-Cola Company and NVIDIA are part of the Zacks top Analyst Blog....…

Top Analyst Reports for UnitedHealth, Johnson & Johnson, & Walmart

Todays Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Johnson & Johnson (JNJ)…

Insiderhandel: Exec VP, Chief HR Officer verkauft Aktien von Johnson & Johnson im Wert von 13.435.616$

Fasolo, Peter - Vorstand - Tag der Transaktion: 2022-10-24...…

Insiderhandel: Vorstand verkauft Aktien von Johnson & Johnson im Wert von 2.573.220$

Hait, William - Vorstand - Tag der Transaktion: 2022-10-24...…

Johnson & Johnson stock outperforms market on strong trading day

Johnson & Johnson stock outperforms market on strong trading day...…

Johnson & Johnson stock underperforms Tuesday when compared to competitors

Johnson & Johnson stock underperforms Tuesday when compared to competitors...…

U.S. FDA Approves TECVAYLI™ (teclistamab-cqyv), the First Bispecific T-cell Engager Antibody for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

TECVAYLI™, an off-the-shelf, subcutaneous therapy, is an important new medicine for patients with incurable blood cancer who face limited treatment…

Johnson & Johnson: Erholungspotenzial - Chartanalyse

Paris (www.aktiencheck.de) - Johnson & Johnson: Erholungspotenzial - Chartanalyse Die Aktie des amerikanischen Pharmakonzerns Johnson & Johnson befindet sich seit ihrem…

Johnson & Johnson stock rises Monday, outperforms market

Johnson & Johnson stock rises Monday, outperforms market...…

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what…

J&J, Alkermes, AbbVie, others set to benefit from expanding schizophrenia drug market

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Exec VP, Chief HR Officer verkauft Aktien von Johnson & Johnson im Wert von 11.535.936$

Fasolo, Peter - Vorstand - Tag der Transaktion: 2022-10-19...…

Johnson & Johnson stock rises Friday, still underperforms market

Johnson & Johnson stock rises Friday, still underperforms market...…

Pharma Stock Roundup: JNJ Q3 Earnings Beat, RHHBY Sales Weak, LLY, ABBV Ink M&A Deals

J&J (JNJ) beats earnings and sales estimates for the third quarter. Eli Lilly (LLY) and AbbVie (ABBV) announce small acquisitions....…

Johnson & Johnson bags $244M defense logistics contract

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Johnson & Johnson stock rises Thursday, outperforms market

Johnson & Johnson stock rises Thursday, outperforms market...…

Regulatory approvals for AbbVie, J&J bolster the Club investment case

Regulators greenlit to two products from AbbVie (ABBV) and Johnson & Johnson (JNJ). Plus, AbbVie made a small biotech acquisition....…

Patients are getting surgeries again, says J&J

J&J said surgical procedure volumes are returning to pre-pandemic levels in many parts of the world....…

Johnson & Johnson stock falls Wednesday, underperforms market

Johnson & Johnson stock falls Wednesday, underperforms market...…

Jim Cramer gives Johnson & Johnson his stamp of approval

Cramer advised investors to buy shares of Johnson & Johnson....…

Johnson & Johnson stock falls Tuesday, underperforms market

Johnson & Johnson stock falls Tuesday, underperforms market...…

Schlussglocke USA: Quartalszahlen treiben Kurse - Salesforce und Johnson & Johnson vorne

Die Aufwärtsbewegung an den US-Börsen ging heute weiter. Immer mehr Unternehmen veröffentlichen derzeit Zahlen, die besser als erwartet ausfallen, auch…

Legend Biotech climbs as analysts parse JNJ Q3 results to estimate Carvykti sales

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Altura Capital Makes Investment in Automation & Validation Solutions, Inc.

Ruben Taborda, former Chief Procurement Officer/Head of Supplier Diversity at Johnson & Johnson has been tapped as AVS new CEO…

Johnson & Johnson (JNJ) Q3 2022 Earnings Call Transcript

JNJ earnings call for the period ending September 30, 2022....…

Johnson & Johnson Stock Can Fly if It Clears This Level

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

J&J (JNJ) Beats on Q3 Earnings, Cuts 2022 Sales View on Fx Woes

J&J (JNJ) beats estimates for third-quarter earnings as well as sales. It lowers the full-year sales guidance. Stock up...…

J&J CFO on Third-Quarter, Outlook, Consumer Spinoff

Um den gesamten Artikel unter bloomberg.com zu lesen, klicken Sie bitte auf die Überschrift...…

J&J stock dip after earnings beat reflects 2022 outperformance rather than the results

It was a solid quarter for Johnson & Johnson, but the strong dollar is and will remain a headwind for…

Johnson & Johnson weighs job cuts ahead of consumer health spinoff

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pre-Markets Rally on Q3 Beats from J&J, Goldman

With the Dow +640 points at this hour, the Nasdaq +280 and the S&P 500 +85 points, its safe to…

Johnson & Johnson: Ordentliches Ergebnis - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von "Der Aktionär": Martin Weiss, stellvertretender Chefredakteur vom Anlegermagazin "Der Aktionär", nimmt die Aktie von…

J&J Profit, Sales Beat While Currency Hit Weighs on Outlook

Um den gesamten Artikel unter bloomberg.com zu lesen, klicken Sie bitte auf die Überschrift...…

US-Marktupdate: Johnson & Johnson und Goldman Sachs im Fokus

Zum Wochenstart hatte die Bullen an der Wall Street das Sagen. Ein überraschend schwacher Empire State Manufacturing Index wirkte sich nicht belastend aus. Veröffentlichte…

Opening Bell: S&P 500, Netflix, Goldman Sachs, Johnson & Johnson, Intel, Microsoft, MongoDB, Amazon

Die US-Indizes starteten gestern mit deutlichen Zugewinnen in die neue Woche. Für den Dow Jones ging es um knapp 1,9…

Gesundheitskonzern Johnson & Johnson spürt Gegenwind durch starken Dollar

Pharmabranche - Der Gegenwind durch den starken US-Dollar hat den Gesundheitskonzern Johnson & Johnson im dritten Quartal gebremst....…

Opening Bell: Wall Street weiter im Aufwind; Johnson & Johnson, Goldman Sachs, Netflix, Microsoft, Intel, MongoDB im Fokus

Unter dem Eindruck starker Unternehmenszahlen deuten sich an den US-Börsen auch am Dienstag Gewinne an. Experten zweifeln derweil daran, wie…

Johnson & Johnson Earnings Top Estimates. Its CFO Explains What Went Right.

A rebound in the medical device business is among the reasons for the company's strong earnings....…